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The discovery that certain mutations result in the production of unfinished,
amino-terminal peptide fragments of the corresponding wild-type proteins suggested
that "nonsense" codons may normally signal termination of polypeptide chain
synthesis.'-3 :\Ioreover, the finding that these "amber" mutations are suppres-
sible, whereby the resulting polypeptide contains serine (codon, UCG) in place of
glutamine (CAG) or tryptophan (UGG),4-6 led to the prediction2 3 that UAG is the
chain terminator of "amber" mutants. The study of other nonsense ("ochre")
mutations suggested further that UAA also functions as a chain termination codon.3
These suggestions were in accord with the fact that no amino acids are coded by
UAG or UAA.7' 8 There are indications that UAA rather than UAG may be the
codon normally concerned with chain termination.9
In vitro experiments with synthetic polynucleotides of random base sequence lent
some support to the view that UAA is involved in chain termination. The poly-
peptides synthesized under the direction of U- and A-containing copolymers or
natural messengers consist largely of free, i.e., released peptide chains, whereas the
peptide chains formed with polynucleotides which do not contain U and A residues
are attached to tRNA.10-12
In order to determine unambiguously whether UAA is a chain-termination codon,
we have studied the in vitro translation of a series of oligonucleotides having, along
with the chain-initiating formylmethionine codon (AUG) and lysine codons (AAA),
leucine (UUA), phenylalanine (UUU), or "ochre" (UAA) codons in specified
sequences as follows: (a) AUGAAAAAAAAA... AAA (AUGA,));- (b) AUGUAA-
AAAAAA...AAA (AUGUA.); (c) AUGUUAAAAAAA... AAA (ATGU2A.);
(d) AUGUUUAAAAAA... AAA (AUGU3A.); (e) AUGUUUUAAAAA... AAA
(AUGU4An).
The (a) polymers promoted the incorporation into acid-insoluble products of
methionine and lysine; the (c) polymers, that of methionine, leucine, and lysine;
and the (d) polymers, that of methionine, phenylalanine, and lysine. On the other
hand, the (b) and (e) polymers promoted the incorporation of only small amounts of
lysine, with little or no incorporation of methionine or phenylalanine. The in-
ference that the (e) oligonucleotides directed the synthesis and release of acid-
soluble formylmethionyl-phenylalanine was proved correct by isolation of the
dipeptide. This work provides conclusive proof that UAA is a chain-termination
codon. It also provides a suitable system for study of the mechanism of chain
termination.
Materials and Methods.-These were as in previous work13 14 unless otherwise noted.
Amino acid incorporation: The low-nuclease system consisting of purified Escherichia coli Q13
ribosomes and Lactobacillus arabinosus supernatant,15 supplemented with initiation factors,13 18
was used throughout. In experiment 1 of Table 1 the samples contained the following components
in a final volume of 0.125 ml: Tris-HCl buffer, pH 7.8, 60 mM; ammoniumn chloride, 50 mM;
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2-mercaptoethanol, 16 mM; magnesium acetate, 14 mM; ATP, 1.2 mrM; GTP, 0.3 mM; phos-
phocreatine, 18 mM; creatine kinase, 9 Mg; E. coli W tRNA, 0.60 mg; purified E. coli Q13 ribo-
somes, 7 A260 units; L. arabinosus supernatant, 0.2 mg of protein; N'0-formyltetrahydrofolic acid
(FTHF), 8 mM; initiation factors (F1 and F2), 6 and 21 ug of protein, respectively; 20 amino
acids (one of them with C14 label), each 0.2 mM; without or with oligonucleotide messenger,
15-20 Mg. The specific radioactivities (Muc/MLmole) of the labeled amino acids were: lysine, 2;
methionine, 20; leucine, 22; and phenylalanine, 40. The composition of the samples in experi-
ment 2 of Table 1 was similar except that only three amino acids, namely, lysine (0.2 mM),
methionine (0.02 mM), and phenylalanine (0.02 mM) were present, one of them having C'4 label.
Their specific radioactivities (,uc/.umole) were: lysine, 10; methionine, 186; and phenylalanine,
176. After incubation at 370 the reaction was terminated by addition of KOH (final concentra-
tion, 0.5 M). The mixtures were kept at 370 for 3 hr, followed by neutralization, and the acid-
insoluble radioactivity was determined as previously described.16
Polynucleotides: The methods used in this laboratory for the preparation of various kinds of
oligonucleotides of specified base sequence have been described.'7 The preparation of the polymers
used in the present work is described below.
AUGA. polynucleotides were preparedl7 with ADP and polynucleotide phosphorylase, using
ApUpG'8 (AUG) as primer. For the other polymers, the series of primers ApUpGpU (AUGU),
ApUpGpUpU (AUGU2), ApUpGpUpUpU (AUGU3), and ApUpGpUpUpU (AUGU4) was pre-
pared by limited addition of uridylic acid residues from UDP to ApUpG primer with polynucleo-
tide phosphorylase and chromatographic isolation of the individual oligonucleotides. Adenylic
acid residues were then added to each of these primers, by incubation with ADP and polynucleotide
phosphorylase. For characterization purposes the polymers were prepared with H3-labeled
guanylic acid residues. In the following description this label will be indicated by an asterisk.
ApUpG* was prepared from ApU (lot no. B 3503, Gallard-Schlesinger) as described previously.'7
ApUpG*pU, ApUpG*pUpU, ApUpG*pUpUpU, and ApUpG*pUpUpUpU were synthesized by
the addition of uridylic acid residues to ApUpG* under the following conditions. The reaction
mixture (pH 8.2) contained the following components (in ,umoles/ml unless otherwise indicated)
in a final volume of 4.0 ml. ApUpG*, 7.3; UDP (lot no. 1116, Pabst), 40; Tris-HCl, 150; mag-
nesium acetate, 10; EDTA, 1; sodium chloride, 500; polynucleotide phosphorylase, 300 ,ug of
protein/ml. After incubation for 20 min at 300, the solution was held at 1000 for 5 min, cooled,
diluted 50-fold, and applied to a column (1.8 X 39 cm) of DEAE-cellulose (lot no. 1675, 1 mEq/
gm, Brown). Oligonucleotides of the form ApUpG* with 1, 2, 3, etc. residues of uridylic acid
added to the 3'-end were separated at 250 by gradient elution with ammonium bicarbonate (0.01
M ammonium bicarbonate, pH 8.6, in a 2-liter mixer; 0.5 M ammonium bicarbonate, pH 8.6,
in a reservoir) at 1 ml/min. In order to remove water and salt, the oligonucleotides were recovered
by flash evaporation and lyophilization. The yields were, in moles of oligonucleotide/mole-in-
put ApUpG*: ApUpG*, 0.142; ApUpG*pU, 0.295; ApUpG*pUpU, 0.166; ApUpG*pUpUpU,
0.119; and ApUpG*pUpUpUpU, 0.072. The structure and purity of each oligonucleotide was
confirmed by paper chromatography in two solvents (solvent 1, 1.0 M ammonium acetate, pH
7.5/95% ethanol, 6/4, v/v; solvent 2, 40 gm ammonium sulfate plus 100 ml of 0.1 M potassium
phosphate, pH 7.0), by degradation with RNase T1 followed by identification of ApUpG*p plus
the expected length of uridylic acid residues (i.e., ApUpG*p plus UpUpU were recovered from
ApUpG*pUpUpU), and by the determination of the ratio of uridine to uridylic acid following
complete alkaline hydrolysis.
Adenylic acid residues were added to the 3'-ends of each of the purified oligonucleotide primers,
and the resulting polymers were fractionated according to chain length and recovered as pre-
viously described.'7' 19 The structure was confirmed by the identification of the low-molecular-
weight products arising from the degradation of each polymer with RNase T1 and by pancreatic
RNase. For example, ApUpG*pUpU(pA). gave rise to ApUpG*p following RNase T1 diges-
tion, and to ApUp, G*pUp, and Up, in the molar ratio 1/1/1 following digestion with pancreatic
RNase.
The polynucleotide phosphorylase was a preparation from Micrococcus lysodeikticus with all
absolute requirement for primer oligonucleotides. The enzyme catalyzed the polymerization of
6.5 ,moles of ADP/min/mg protein at 370 under the following conditions (reagents in ,moles/ml):
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ADP, 40; ApApA, 1; sodium chloride, 500; magnesium acetate, 10; EDTA, 1; and Tris-HCl
buffer, pH 8.2, 150.
Isolation and characterization of (H')formnyl-(C'4)methionyl-(C"2)phenylalanine and (H3)formyl-
(Cl2)methionyl-(C'4)phenylalanine: The incubation mixtures were as described under Amino Acid
Incorporation (expt. 1 of Table 1) with the following exceptions: H3-FTFH (formate-labeled,
2000 ,Ac/,gmole), 0.022 mM; either C14-methionine (186 l&c/lMmole) or CL4-phenylalanine (352
/Ac/,umole), 0.02 mM; nonlabeled amino acids, either 19 amino acids, each 0.2 mM, or lysine
(0.2 mM) and phenylalanine or methionine (0.02 mM); without or with AUGU4AjI-, 15-20 Mug.
Pancreatic DNase (electrophoretically purified, Worthington), 25 Ag, was also added to the
samples to prevent any synthesis of endogenous messenger RNA.
Prior to adding the ribosomes, the samples were incubated for 5 min to allow time for transfer
of H3-formate from H3-FTFH to met - tRNAFY20 The ribosomes were then added and the
incubation was continued for 15 min. The short incubation was chosen to minimize enzymatic
removal of labeled formyl residues from the peptides synthesized. After incubation, the samples
were chilled in ice and treated with 0.127 ml of 6% perchloric acid. The precipitate was removed
by centrifugation and washed three times with 30-,ul portions of ice-cold 3% perchloric acid.
The combined supernatant and washings were neutralized with 0.168 ml of 1.0 N KOH. The
potassium perchlorate precipitate was removed by centrifugation and washed repeatedly with
50-MI& portions of cold water until the washings were free of radioactivity. The supernatant and
the washings were combined and the pH of the solution was adjusted to 7.8, with Tris-HCl buffer,
prior to chromatography on a Dowex-1 (Cl-) column (0.6 X 5 cm). The column was washed
with 10 ml of water, containing 1-2 mg of nonlabeled phenylalanine or methionine, and the
formylated amino acids and peptides were then eluted with 8.0 ml of 0.5 N acetic acid adjusted
to pH 2.7 with pyridine. This solution was passed through a Dowex-50 (H+) column (0.6 X
20 cm). The formylated compounds were washed through with 8.0 ml of 0.001 N HCl. For
separation of formylmet and formylmet-phe, the eluate was lyophilized, the residue taken up in
0.5 ml of water, and aliquots of the solution were subjected to high-voltage paper electrophoresis,
along with markers of formylmet and formylmet-phe, as previously described,'4 except that the
electrophoresis was run for 7 hr. For measurement of radioactivity after electrophoresis, the
paper was cut into strips (1 cm long, 2.5 cm wide) which were placed in the bottom of scintillation
vials. The strips were covered with solvent (4 gm of 2,5-diphenyloxazole (PPO) and 50 mg of
p-bis [2-(5-phenyloxazolyl)]-benzene (POPOP) per liter of toluene) and the radioactivity was
measured in a Packard Tri-Carb scintillation spectrometer. Under these conditions, the counting
efficiency of the two isotopes on Whatman 3MM paper was about 29% for C14 and 0.9% for HI,
with 12% of the C'4 counts appearing in the HI channel, and less than 0.1% of the H' counts in
the C14 channel. The total amount of formylmet-phe calculated from the electrophoretic data
was corrected for small aliquots of material withdrawn, during the processing of the reaction
mixtures, for determination of the acid-soluble radioactivity. This correction was never greater
than 6%.
Formylmet-phe was prepared by formylation ofL-methionyl-I-phenylalanine." L-methionyl-
L-phenylalanine was obtained from the Mann Research Laboratories, Inc., New York.
Results and Discussion.-Incorporation of amino acids into acid-insoluble products:
As shown in Table 1, oligonucleotides of the series AUGAn, AUGUAn, and AUGUr-
An promote the incorporation of lysine, along with smaller amounts of methionine
(AUGUj-), methionine and leucine (AUGU2A-o), and methionine and phenylalanine(AUGU3Ai-). It may further be noted that the incorporation of methionine and
leucine, or methionine and phenylalanine, promoted by poly AUGU2A-o or AUGU3-
Al-, respectively, is roughly equimolar. Moreover, there is negligible or no in-
corporation of phenylalanine with poly AUGU2Aio and the same is true of leucine in
the case of poly AUGU3Ajo. This shows that these polymers are read in phase from
the 5'-end.
In contrast to the above results, the incorporation of the various amino acids into
acid-insoluble material is markedly diminished when oligonucleotides of the series
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TABLE 1
POLYPEPTIDE SYNTHESIS WITH OLIGONUCLEOTIDE MESSENGERS OF SPECIFIED BASE SEQUENCE*
Incubation Amino Acid Incorporationt_
Expt. time Phenyl-
no. (min) Messenger Lysine Methionine Leucine alanine
1 40 None (blank) 81 43 24 18
AUGArs 1261 (1521) 163 (152) 0 0
AUGUAn1 162 (142) 10 (10) 0 0
AUGUIAro 644 (563) 65 (58) 56 (51) 0
AUGU3Ajo 543 (425) 56 (47) 2 62 (50)
AUGUeAro 282 (153) 10 (10) 2 4 (9)
2 15 None (blank) 43 3 5
AUGUsAro 371 29 21
* Conditions as described under Materials and Methods. In expt. 2 the samples were preincubated for 5
min prior to starting the reaction by addition of the ribosomes.
t Values expressed in g1umoles/sample. The first line for each expt. gives the blank values in the absence
of added oligonucleotide. All others are net values, the blanks without polymer having been subtracted
from the values with polymer. The net values given in parentheses are the combined averages of expt. 1
and three other experiments carried out at different times between August 1966 and February 1967. Dupli-
cate samples were run in each experiment and the results averaged.
AUGU4An (AUGU4A0), having the UAA triplet in the third position from the 5'-
terminus, are used as messengers. Although there is some lysine incorporation,
that of methionine and phenylalanine is very low. This incorporation is referable
to slight contamination of poly AUGU4An with AUGU3An. Table 1 also lists an
experiment with poly AUGUA11, having the UAA triplet in the second position from
the 5'-end. Some lysine but little if any methionine is incorporated.
Release of formylmethionyl-phenylalanine upon translation of A UGU4A5 polymers:
In order to determine whether acid-soluble formylmet-phe is synthesized and
released upon translation of the AUGU4An messengers, incubations with and with-
out polymer were conducted with either H3-FTHF and C14-methionine or H3-FTHF
and C14-phenylalanine. The nonlabeled amino acids were either 19 amino acids (no
methionine or no phenylalanine) or lysine with either phenylalanine or methionine.
After incubation, any labeled acid-insoluble products, including formylmet
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FIG. 1.-Electrophoretic patterns of labeled peptides synthesized with AUGU4Aii oligonucleotide
messenger. Aliquots corresponding to 10% of the sample were used for electrophoresis. The
anode is to the right. The position of formylmet-phe and formylmet markers is indicated. (A)
Incubation with H3-FTHF and C"-phenylalanine. (B) Incubation with H3-FTHF and C14-
methioniine. In this experiment the samples contained the remaining 19 C'4-amino acids. Two
other experiments were carried out with similar results. Squares, blank samples (no oligonucleo-
tide added); circles, samples with oligonucleotide added. Open symbols s(O, 0), H3 label; solid
symbols (U, *), C'4 label.
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TABLE 2
H3 AND C14 RADIOACTIVITY IN THE FORMYLMETHIONYL-PHENYLALANINE AREA OF THE
ELECTROPHEROGRAMS OF FIGURE 1*
Blank Sample with Polymer-
samplet AUGIT4A- promoted
Expt. Radioactive label (a) (b) (b a)
Fig. 1A HI (formate) 3.4 32.1 28.7
C14 (phenylalanine) 2.5 26.2 23.7
Fig. 1B H3 (formate) 4.8 32.6 27.8
C'4 (methionine) 7.3 34.2 26.9
Values expressed as pmoles of formate, phenylalanine, or methionine/sample.
t Sample with no oligonucleotide added.
tRNAF, met -- tRNAM, and phe - tRNA, were removed by precipitation with per-
chloric acid and the supernatants worked up as described under Materials and
Methods.
The electrophoretic patterns of the H3- and C14-labeled products (Fig. 1) show
two main peaks. One of them is in the position of formylmet-phe, the other in the-
position of formylmet. The presence of formylmet would appear to reflect the oc-
currence of some deacylation of formylmet - tRNAF during the incubation. It
may be noted that the blank incubations, with no added oligonucleotide, show
roughly the same amount of radioactivity in the position of formylmet but little
or no radioactivity in the region of the dipeptide.
The H3 and C14 radioactivity under the formylmet-phe peak, expressed asuu-
moles of product per incubation sample, is given in Table 2. Reference to experi-
ment 2 of Table 1 shows that the formation of formylmet-phe with poly AUGU4Ate
is of the same order of magnitude as the incorporation of methionine and phenyl-
alanine into acid-insoluble material with AUGU3Aio messenger.
The above results indicate that the AUGU4An polymers are translated with the
same efficiency as the others except for termination of chain growth and release
once formylmet-phe is synthesized. It may be emphasized in this connection that
formylmet-phe is not released as peptidyl -- tRNA (a compound that would be acid-
insoluble) but as the free dipeptide. Thus, complete chain termination is achieved.
The isolation of formylmet-phe in good yields, upon translation of the 5'-end sextet
AUGUUU, also provides further proof for the triplet nature of the genetic code.23
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